section name header

Y-Site Injection Compatibility (1:1 Mixture)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mLa)

I

Furosemide

(Mfr: AMR)(Conc: 5 mg/mLa)

Remarks:

Haze forms immediately with precipitate after 30 min

Ref:

2928